Abstract
Background and objective
The research on the effect of anesthesia on endovascular therapy (EVT) of acute ischemic stroke is mainly focused on the anterior circulation, and little is known about the data of basilar artery occlusion (BAO). This study aims to investigate the association of anesthesia strategy with 90-day clinical outcomes of patients with acute BAO treated with EVT.
Methods
We reviewed our prospectively collected data from the endovascular treatment database at the Beijing Tiantan Hospital. This included patients with acute BAO who had a documented 90-day modified Rankin Scale (mRS) score from January 2012 to July 2018. Options for EVT included general anesthesia (GA) and conscious sedation (CS) performed by an anesthesia care team in the institution. The recommendation of anesthesia for patients was a joint decision between anesthesiologist and neurointerventionalist according to a pre-designed scheme. Patients who required tracheal intubation for airway protection prior to EVT were excluded. The clinical outcomes we observed were functional independence (mRS ≤2), favorable outcome (mRS ≤3), and mortality at 90 days after the procedure. Univariate and multivariable logistic regression analyses were used to explore the relationship between anesthesia methods and 90-day outcomes.
Results
A total of 187 patients with BAO were treated by EVT in this study. Nine cases requiring emergent intubation prior to EVT were excluded. 139 patients (78.1%) underwent GA and 39 patients (21.9%) underwent CS. In univariate analysis, GA was associated with less functional independence [odds ratio (OR), 0.28; 95% confidence interval (CI), 0.13–0.59] and less favorable outcome (OR, 0.23; 95% CI, 0.10–0.52) than was CS. After adjusting for potential confounders, multivariable analysis showed that there were still significant differences between GA and CS in functional independence (OR, 0.31; 95%CI, 0.10–0.97) and favorable outcome (OR, 0.24; 95%CI, 0.07–0.75).
Conclusion
Our retrospective analysis suggested that the anesthesia strategy may affect outcome, in which general anesthesia may result in less favorable outcomes. Nevertheless, future multicenter randomized controlled trials are needed to confirm our findings.
Keywords: Anesthesia, Basilar artery occlusion, Endovascular therapy, Outcome
Background
Basilar artery occlusion (BAO) accounts for 1% of all strokes and 8% of symptomatic posterior circulation ischemia strokes [1], with a high mortality about 80% or more in patients treated conventionally [2]. Recently, with the development of noninvasive imaging with computed tomography and magnetic resonance techniques and invasive imaging with digital subtraction angiography, the diagnosis and treatment of BAO has greatly improved. Therefore, BAO has evolved from a nearly fatal disease to a treatable one [1]. The modern endovascular therapy (EVT) technique involving stent-retrievable mechanical thrombectomy has been validated in several large randomized controlled trials (RCTs) related to anterior circulation [3–6]. It is also effective and safe to use the same technique for BAO [7]. The recanalization rate has been improved by the use of stent retrievers, and approximately 80–90% of all blocked basilar arteries can be recanalized with current endovascular treatment [1]. However, despite these improvements in treatment, more than one in two patients still experience functional dependency [modified Rankin Scale (mRS) score > 2 after 3 months] [1, 8]. Clinical outcomes depend on patient-specific factors and procedure considerations [9]. Previous studies have suggested that anesthetic management during EVT may substantially affect outcomes of anterior circulation stroke (ACS) [10, 11].
Previous retrospective studies have suggested that general anesthesia (GA) may be associated with worse outcomes than conscious sedation (CS) for EVT [12, 13]. In contrast, some prospective studies have shown that outcomes were equivalent or better with GA than CS for anterior circulation thrombectomy [14–16]. However, posterior circulation stroke (PCS) is different from ACS in stroke etiology and outcome, because PCS is more often due to atherosclerosis [1], while ACS is more often classified as cardioembolic stroke [17]. The effect of anesthesia type of PCS on clinical outcomes seems to be different from ACS and the data on anesthesia used in patients with BAO is rare [9]. Consequently, the relationship between anesthesia and prognosis of patients with BAO after EVT is still uncertain.
To date, one study focused on posterior circulation stroke has been published, showing that monitored anesthesia care is as safe and effective as GA [9]. This study included all vertebrobasilar occlusion strokes. We therefore used a retrospective design to explore the effect of the type of anesthesia (GA and CS) on the outcomes of patients who received EVT in the setting of acute BAO.
Methods
Study population
This study involved a retrospective analysis examining the effect of the type of anesthesia on the outcomes of consecutive patients with BAO treated by EVT at the Beijing Tiantan Hospital. Patients admitted between January 2012 and July 2018 were included and those who required emergent intubation prior to EVT were excluded. All protocols were approved by the Institutional Review Board of Beijing Tiantan Hospital, and all patients or their relatives provided written consent for participation.
Baseline data collection
Clinical baseline variables, including age, sex, vascular risk factors, mode of stroke onset, blood pressure, stroke severity as expressed by the National Institutes of Health Stroke Scale (NIHSS) score, laboratory tests, imaging modality, anatomical and morphological characteristics of BAO, stroke type according to the Trial of Org 10,172 in Acute Stroke Treatment (TOAST) classification [18], perioperative management, details of EVT, postsurgical modified Thrombolysis in Cerebral Infarction (mTICI) score [19], and clinical outcomes within 90 days, were prospectively collected. The time of BAO onset as described by the patients or witnesses was also prospectively recorded; if unknown, it was considered to be the last time the patient was found well. In patients with mild symptoms followed by a sudden onset of decreased consciousness, the time of deterioration of clinical status was estimated as the time of BAO onset.
Anesthesia management
The anesthesia strategy was pre-designed based on the Practice Guidelines for Sedation and Analgesia by Non-Anesthesiologists, due to the continuum ranging of level of sedation from minimal sedation to GA [20]. The recommendation of anesthesia for patients was a joint decision between anesthesiologist and neurointerventionalist. Patients with clear consciousness and satisfactory airway reflex function are often recommended to undergo CS, while patients with poor preoperative consciousness and poor airway protective reflex are typically treated with general anesthesia. The target systolic blood pressure (SBP) before recanalization was maintained at 140-160 mmHg. Patients whose blood pressure was lower than this standard after sedation should undergo vasopressor medications to maintain blood pressure. For patients in the GA group, anesthesia was induced with sufentanil (0.2 μg/kg) or propofol (1–2 mg/kg). Muscle relaxation was achieved with rocuronium (0.6 mg/kg), followed by placement of a laryngeal mask or endotracheal intubation for providing mechanical ventilation to maintain end tidal carbon dioxide tension levels of 35–40 mmHg. Anesthesia was maintained with infusions of remifentanil at 0.1–0.2 μg/kg/min and propofol at 2–6 mg/kg/h. In the CS group, sedation was achieved with a low dose of propofol (2–4 mg/kg/h), and patients were given supplemental oxygen via a face mask. Anesthesiologists were involved in all procedures.
Outcome measurement
The modified Rankin Scale (mRS) was used to evaluate functional outcomes at 90 days. Follow-up was conducted via telephone interview by trained assessors who were not involved in the study procedure. According to the Basilar Artery International Cooperation Study definition [21], functional independence was defined as mRS ≤2, and favorable outcome was defined as mRS ≤3. In this study, the clinical outcome measures were functional independence, favorable outcome and death at 90 days after the procedure.
Statistical analysis
Study data were collected on standard forms, evaluated for completeness, and double keyed into an EpiData statistics data document. The baseline and outcome data were described using means (standard deviations) for normally distributed continuous variables or medians (25th and 75th percentiles) for non-normally distributed continuous and ordinal variables. Frequencies or proportions were used for categorical variables. Independent-samples t-test was used for normally distributed continuous variables, Mann-Whitney U test for non-normally distributed continuous and ordinal variables, while Pearson’s chi-square test or Fisher’s exact test was used to compare the frequencies or proportions between the CS and GA groups. For comparing the 90-day outcomes between both groups, odds ratios (ORs) with 95% confidence intervals (CIs) and adjusted ORs with 95% CIs were calculated using univariate and multivariable logistic regression models. To improve the reliability of the results, three multivariable regression models were used. In model 1, we adjusted only for age, sex, NIHSS, and median time of onset to puncture. In model 2, we additionally adjusted for the baseline variables with a difference at a level of P < 0.1 between both groups. In model 3, we further adjusted for the confounders selected on the basis of the change-in-estimate criterion, by which a variable can be included in the final model if its inclusion in the regression model [logit(Y) = β0 + β1 × X + β2 × Z, where X indicates the type of anesthesia, Y indicates the 90-day outcome, and Z indicates the included variable] produced a change in the regression coefficient of “X” by at least 10% compared with the one in the basic regression model [logit(Y) = β0 + β1 × X] [22]. Statistical significance was set at P < 0.05. All statistical analyses were performed with the statistical software package R (http://www.R-project.org, The R Foundation) and Empowerstats (http://www.empowerstats.com, X&Y Solutions, Inc., Boston, MA).
Results
Patient characteristics
A total of 221 consecutive patients with PCS were treated with emergency EVT, including 187 patients with BAO. Nine patients with BAO who required emergent intubation prior to EVT were excluded in this analysis (Fig. 1). Their average age was 60 ± 10 years, 150 patients (84.3%) were men. The median admission NIHSS score was 20.5 [interquartile range (IQR) 10–33], 130 patients (73.0%) were treated by stent-retriever thrombectomy, the median time from onset to puncture was 7 (IQR 5–10) hours. In 151 cases (84.8%), patients were successfully recanalized (mTICI 2b-3). In all, 139 patients (78.1%) underwent GA and 39 patients (21.9%) underwent CS.
Fig. 1.
Flow chart of the study sample. BAO indicates basilar artery occlusion; CS, conscious Sedation; GA, general anesthesia; mRS, modified Rankin Scale
Baseline characteristics and procedural parameters are summarized in Table 1. Patients who underwent GA had higher NIHSS scores on admission [22 (IQR 11–35) versus 16 (IQR 6–30) points, P = 0.04], more often underwent thrombectomy using a stent retriever (79.1% versus 51.3%), more time needed to maintain anesthetic sedation [1.5 (IQR 1–2) versus 1 (IQR 1–2) hours, P = 0.01)], and more often received an infusion of tirofiban (73.4% versus 53.8%, P = 0.02). Compared the CS group, the GA group showed a different tendency with respect to sex distribution (87.1% versus 74.4%, P = 0.05), previous ischemic stroke (17.3% versus 30.8%, P = 0.07), blood glucose (8.6 mmol/L versus 9.8 mmol/L, P = 0.05), and mode of stroke onset (acute, 48.2% versus 53.8%; progressive, 48.9% versus 35.9%; and fluctuating, 2.9% versus 10.3%; P = 0.08). There were no significant differences between the groups in age (60 ± 10 years versus 60 ± 11 years, P = 0.96), onset to treatment time [7 (IQR 5–10) versus 7 (IQR 5–13) hours, P = 0.71], puncture to recanalization time [1 (IQR 0.5–2) versus 1 (IQR 0.5–2) hours, P = 0.34)], or successful recanalization (84.9% versus 84.6%, P = 0.97).
Table 1.
Baseline characteristics of patients under GA and CS
| Variable name | Overall (n = 178) | GA (n = 139) | CS (n = 39) | P |
|---|---|---|---|---|
| Demographic data | ||||
| Age, mean (SD), years | 60 (10) | 60 (10) | 60 (11) | 0.96 |
| Male sex | 150 (84.3) | 121 (87.1) | 29 (74.4) | 0.05 |
| Vascular risk factors | ||||
| Hypertension | 125 (70.2) | 99 (71.2) | 26 (66.7) | 0.58 |
| Diabetes mellitus | 50 (28.1) | 41 (29.5) | 9 (23.1) | 0.43 |
| Dyslipidemia | 29 (16.3) | 26 (18.7) | 3 (7.7) | 0.14 |
| Coronary heart disease | 21 (11.8) | 16 (11.5) | 5 (12.8) | 0.78 |
| Previous ischemic stroke | 36 (20.2) | 24 (17.3) | 12 (30.8) | 0.07 |
| Current smoking | 66 (37.1) | 52(37.4) | 14 (35.9) | 0.86 |
| Clinical characteristics | ||||
| Mode of stroke onset | 0.08 | |||
| Acute | 88 (49.4) | 67 (48.2) | 21(53.8) | |
| Progressive | 82 (46.1) | 68 (48.9) | 14 (35.9) | |
| Fluctuating | 8 (4.5) | 4 (2.9) | 4 (10.3) | |
| Pre-procedural SBP, mean (SD),mmHg | 160(25) | 160(26) | 160 (24) | 0.86 |
| Post-procedural SBP, mean (SD),mmHg | 144 (21) | 143 (22) | 146 (19) | 0.57 |
| NIHSS score, median (IQR) | 20.5 (10–33) | 22 (11–35) | 16(6–30) | 0.04 |
| mRS before stroke, median (IQR) | 0 (0–0) | 0 (0–0) | 0 (0–0) | 0.30 |
| WBCs, mean (SD), ×1 09 | 10.8 (3.8) | 11.0 (3.7) | 10.3 (4.0) | 0.29 |
| Blood glucose, mean (SD), mmol/L | 8.8 (3.5) | 8.6 (3.2) | 9.8 (4.4) | 0.05 |
| Creatinine, mean (SD), umol/L | 70.0 (21.7) | 71.5 (20.7) | 64.8 (24.7) | 0.10 |
| pc-ASPECTS on DWI, median (IQR) | 6 (5–8) | 7 (5–8) | 6 (4–8) | 0.81 |
| PMI on DWI, median (IQR) | 2 (0–4) | 2 (0.25–4) | 2 (0–3) | 0.58 |
| Occlusion site | 0.99 | |||
| Proximal BA | 100 (56.2) | 78 (56.1) | 22 (56.4) | |
| Middle BA | 51 (28.7) | 40 (28.8) | 11 (28.2) | |
| Distal BA | 27 (15.2) | 21 (15.1) | 6 (15.4) | |
| Tandem lesion | 24 (13.5) | 17 (12.2) | 7 (17.9) | 0.36 |
| Underlying ICAS | 111 (62.4) | 89 (64.0) | 22 (56.4) | 0.39 |
| ASITN/SIR collateral system | 0.68 | |||
| Grade 0–1 | 76 (42.7) | 61 (43.9) | 15 (38.5) | |
| Grade 2 | 81 (45.5) | 63 (45.3) | 18 (46.2) | |
| Grade 3–4 | 21 (11.8) | 15 (10.8) | 6 (15.4) | |
| Stroke subtype by TOAST criteria | 0.82 | |||
| Large artery arteriosclerosis | 143 (80.3) | 112 (80.6) | 31 (79.5) | |
| Cardioembolic | 28 (15.7) | 21 (15.1) | 7 (17.9) | |
| Other or unknown etiology | 7 (3.9) | 6 (4.3) | 1 (2.6) | |
| Procedural features | ||||
| Prior use of intravenous tPA | 35 (19.7) | 26 (18.7) | 9 (23.1) | 0.54 |
| Use of Solitaire retriever | 130 (73.0) | 110 (79.1) | 20 (51.3) | < 0.01 |
| No. of passes, median (IQR) | 1 (1–2) | 1 (1–2) | 1 (1–2) | 0.44 |
| Intra-arterial tPA or Urokinase | 40(22.5) | 29 (20.9) | 11 (28.2) | 0.33 |
| Infusion of Tirofiban | 123 (69.1) | 102 (73.4) | 21 (53.8) | 0.02 |
| Heparinization | 76 (42.7) | 60 (43.2) | 16 (41.0) | 0.81 |
| Angioplasty | < 0.01 | |||
| No | 57 (32.0) | 36 (25.9) | 21 (53.8) | |
| Balloon alone | 31 (17.4) | 25 (18.0) | 6 (15.4) | |
| stenting | 90 (50.6) | 78 (56.1) | 12 (30.8) | |
| OTP, median (IQR), hours | 7 (5–10) | 7 (5–10) | 7 (5–13) | 0.71 |
| PTR, median (IQR), hours | 1(0.5–2) | 1(0.5–2) | 1(0.5–2) | 0.34 |
| Anesthesia time (IQR), hours | 1.5 (1–2) | 1.5 (1–2) | 1 (1–2) | 0.01 |
| Successful recanaliation (mTICI 2b-3) | 151 (84.8) | 118 (84.9) | 33 (84.6) | 0.97 |
Values are numbers with percentages in parentheses, unless indicated otherwise
GA indicates general anesthesia, CS conscious sedation, SD standard deviation, SBP systolic blood pressure, NIHSS National Institutes of Health Stroke Scale, mRS modified Rankin Scale, WBC white blood cell, IQR interquartile range, pc-ASPECTS posterior circulation Acute Stroke Prognosis Early CT Score, DWI diffusion weighted imaging, PMI Pons-Midbrain Index, BA basilar artery, ICAS intracranial atherosclerotic stenosis, ASITN/SIR American Society of Interventional and Therapeutic Neuroradiology/Society of Interventional Radiology, TOAST Trial of Org 10,172 in Acute Stroke Treatment, tPA tissue plasminogen activator, OTP onset-to-puncture time, PTR puncture to recanalization time, mTICI modified Thrombolysis In Cerebral Infarction scale
Association of anesthesia with 90-day outcomes in univariate analysis
The functional and favorable outcomes and mortality at 90 days are given in Table 2 and the distribution of mRS at 90-day is presented in Fig. 2. A total of 43 patients (30.9%) who underwent GA and 24 patients (61.5%) who underwent CS had functional independence (mRS 0–2). A favorable outcome (mRS 0–3) was seen in 60 patients (43.2%) who underwent GA and in 30 patients (76.9%) who underwent CS. At 90 days, 29 patients (20.9%) who underwent GA and 3 patients (7.7%) who underwent CS had died. In univariate analysis, GA was associated with less functional independence (OR, 0.28; 95% CI, 0.13–0.59; P < 0.01) and less favorable outcome (OR, 0.23; 95% CI, 0.10–0.52; P < 0.01) than was CS. There was no significant difference in mortality between the GA and CS group (P = 0.07).
Table 2.
Comparison of 90-day outcome between patients under GA and CS
| Outcome variable | GA | CS | Univariate analysis | Multivariable analysis | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Model 1 | Model 2 | Model 3 | ||||||||
| cOR (95% CI) | P value | aOR (95% CI) | P value | aOR (95% CI) | P value | aOR (95% CI) | P value | |||
| Functional independence (mRS 0–2) at 90 days | 43/139 (30.9) | 24/39 (61.5) | 0.28(0.13–0.59) | < 0.01 | 0.31(0.13–0.75) | 0.01 | 0.29 (0.09–0.97) | 0.045 | 0.31(0.10–0.97) | 0.045 * |
| Favorable outcome (mRS 0–3) at 90 days | 60/139 (43.2) | 30/39 (76.9) | 0.23(0.10–0.52) | < 0.01 | 0.26(0.10–0.64) | < 0.01 | 0.25 (0.07–0.83) | 0.02 | 0.24(0.07–0.75) | 0.02 † |
| Death at 90 days | 29/139 (20.9) | 3/39 (7.7) | 3.16(0.91–11.01) | 0.07 | 2.57(0.70–9.52) | 0.16 | 3.36 (0.48–23.68) | 0.22 | 2.99(0.46–19.74) | 0.25 ‡ |
Model 1 adjusted for age, sex, from vascular occlusion to puncture, NIHSS score
Model 2 adjusted for age, sex, from vascular occlusion to puncture, NIHSS score, previous ischemic stroke, Mode of stroke onset, Blood glucose, Use of Solitaire retriever, Infusion of Tirofiban, Angioplasty
GA indicates general anesthesia, CS conscious sedation, cOR crude odds ratio, aOR adjusted odds ratio, CI confidence interval, mRS modified Rankin Scale
*Adjusted for age, sex, from vascular occlusion to puncture, NIHSS score, previous ischemic stroke, angioplasty, anesthesia time
†Adjusted for age, sex, from vascular occlusion to puncture,NIHSS score, use solitaire retriever, blood glucose, anesthesia time
‡Adjusted for age, sex, from vascular occlusion to puncture, NIHSS score, previous ischemic stroke, blood glucose, use of solitaire, angioplasty, anesthesia time
Fig. 2.
The Distribution of mRS at 90-day stratified by GA and CS. CS indicates conscious Sedation; GA, general anesthesia; mRS, modified Rankin Scale
Association of anesthesia with 90-day outcomes in multivariable analysis
In model 1, there were significant differences between GA and CS in functional independence (OR, 0.31; 95% CI, 0.13–0.75; P = 0.01) and favorable outcome (OR, 0.26; 95% CI, 0.10–0.64; P < 0.01). There was no significant difference in mortality between GA and CS (P = 0.16). In model 2, patients who underwent GA had less functional independence (OR, 0.29; 95%CI, 0.09–0.97; P = 0.045) and less favorable outcomes (OR, 0.25; 95%CI, 0.07–0.83; P = 0.02) than those who underwent CS. There was no significant difference in mortality between GA and CS (P = 0.22). In model 3, GA was still associated with less functional independence (OR, 0.31; 95% CI, 0.10–0.97; P = 0.045) and a less favorable outcome (OR, 0.24; 95% CI, 0.07–0.75; P = 0.02) than was CS. There was no significant difference in mortality between GA and CS (P = 0.25).
Discussion
Many patients with acute BAO need intubation and ventilation, analgesia-based sedation. Some neurointerventionalists prefer GA during EVT because patients can remain motionless for safer intracranial navigation of devices and better imaging. However, a consensus about the effect of anesthesia has not been reached. Therefore, we hoped to explore this critical issue in this study. We found that functional independence (mRS 0–2) and favorable outcomes (mRS 0–3) at 90 days after the EVT were significantly different between the patients who underwent GA and those who underwent CS, but mortality did not differ between the two groups. Patients treated with GA may have a worse clinical prognosis after EVT in the setting of acute BAO than those treated with CS.
In our study, GA was in form of induction + airway + a slightly higher dose of propofol, and propofol was used to maintain anesthesia, without using gas inhalation, while a low-dose of propofol was used for CS. This anesthetic strategy was similar to two other anterior circulation-based trials (SIESTA and GOLIATH) [16, 23]. Previous studies have shown that propofol can reduce cerebral blood flow (CBF) and cerebral metabolic rate of oxygen in a dose-dependent manner [24, 25]. However, no enough clinical evidence has been reported to support the use of any anesthetic agents in GA [15, 16, 23]. Moreover, the PCS, especially BAO, mostly involves the brainstem. Harbouring numerous vital nucleus such as respiratory, heartbeat and blood pressure control centers, where the collateral circulation of blood flow exists anterior circulation reflux, but it is still relatively fragile. In our study, we found that BAO patients treated with GA was associated with worse clinical outcomes than those treated with CS. Thereby, we proposed that we should pay more attention to anesthesia strategy and the control of deep anesthesia while actively carrying out mechanical endovascular therapy.
In addition, the results in the present study are consistent with those of other retrospective studies that have found inferior neurological outcomes with GA as opposed to CS for patients presenting with anterior circulation strokes [12, 13, 26]. Berkhemer et al. [13] performed a post hoc analysis of the use of CS in the endovascular treatment of the MRCLEAN trial, and found a worse clinical outcome in those patients who underwent GA compared with patients who underwent CS. This may be because of higher stroke severity, hypotension, or hypocapnia during the procedure under GA, causing a poor prognosis. Studies have shown that hypotension may enhance risk to the ischemic penumbra and hypocapnia potentially leading to brain tissue hypoxia in the ischemic penumbra [27, 28]. Other prospective studies, such as the ANSTROKE study [15], showed no difference between the two anesthetic techniques in neurological outcome 3 months after stroke. Similarly, the SIESTA [16] and GOLIATH [14] studies demonstrated no advantage in the use of CS over GA. The different findings between the prospective studies and the retrospective studies may expose the problem of confounders in terms of the different designs. Many confounders, such as the basic characteristics of patients, onset to treatment time, effect of anesthetic factors, the sites of occlusion, and procedural features, may lead to inconsistencies.
However, most studies have limited enrollment to patients with acute anterior circulation occlusions, and only few studies have focused on the anesthesia for EVT for acute stroke in the posterior circulation. Jadhav et al. [9]. in their study indicated that monitored anesthesia care was safe and effective in EVT for acute vertebrobasilar occlusion strokes. They lacked the imaging data of patients and assessment of collateral circulation, which might affect the results. There are several limitations to our study. First, because our study was a single-center retrospective cohort study, and not an RCT, there may be a selection bias between the two groups, especially in patients with GA with high NIHSS scores. However, we used three multivariable regression models, in which the NIHSS score was adjusted as a confounding factor. Besides, a randomized controlled study, namely the “Choice of Anesthesia for Endovascular Treatment of Acute Ischemic Stroke at Posterior Circulation: Protocol for an Exploratory Randomized Controlled Study [29]” was already in progress. Second, we did not investigate periprocedural blood pressure fluctuations, changes in blood oxygen concentrations, or complications such as rates of aspiration pneumonia and subsequent intubation, which may have influenced our results. Although adjusted by models, potential confounders that we did not or could not measure may have influenced the outcome. Third, the sample size was relatively limited, especially the number of patients with CS. Any try of matching correction or propensity score matching (PSM) between the GA and CS would further reduce the sample size, but would bring statistical bias. Thereby, three multivariable logistic regression models rather than matching correction or PSM were used to adjust NIHSS score. In future research, we needed to further expand the sample size. Given these limitations, our results should be carefully interpreted.
Conclusion
In our study, GA for endovascular intervention in patients with acute BAO was associated with worse neurological outcomes than those associated with CS, but GA did not increase mortality. This suggests that anesthesia may affect the prognosis of patients with acute BAO who undergo EVT. Future multicenter RCTs are needed to determine which type of anesthesia may be better for patients with acute BAO undergoing EVT.
Declarations
We thank all relevant clinicians, statisticians, and imaging and laboratory technicians.
Abbreviations
- ACS
Anterior circulation stroke
- BAO
Basilar artery occlusion
- CI
Confidence interval
- CS
Conscious sedation
- EVT
Endovascular therapy
- GA
General anesthesia
- IQR
Interquartile range
- mRS
Modified Rankin Scale
- mTICI
Modified Thrombolysis in Cerebral Infarction
- NIHSS
National Institutes of Health Stroke Scale
- OR
Odds ratio
- PCS
Posterior circulation stroke
- PSM
Propensity score matching
- RCTs
Randomized controlled trials
- SBP
Systolic blood pressure
- TOAST
Trial of Org 10,172 in Acute Stroke Treatment
Authors’ contributions
HD, XT, ZM and DZ designed this research; HD, XT, XS, ZS, BL and FG collected and interpreted the data; ZM and DZ designed research, collection, analysis, and interpretation of data; HD and XT wrote the manuscript. All authors read and approved the final manuscript.
Funding
This study was funded by the National Key Research and Development Program of China (No.2016YFC1301500), China Postdoctoral Science Foundation (No.2019 M650773), Hebei Provincial Health and Family Planning Commission (No.20181258 and 20181264).
The funding body did not play any role in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript.
Availability of data and materials
The datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request.
Ethics approval and consent to participate
All protocols were approved by the Institutional Review Board of Beijing Tiantan Hospital. The appropriate permissions to access the patient database which provided the data for our study were granted by Beijing Tiantan Hospital.
Consent for publication
Not applicable.
Competing interests
The authors have no financial conflicts of interest.
Footnotes
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Haibin Du and Xu Tong contributed equally to this work.
Contributor Information
Zhongrong Miao, Email: zhongrongm@163.com.
Dong Zhang, Email: zhangdong0660@aliyun.com.
References
- 1.Mattle HP, Arnold M, Lindsberg PJ, Schonewille WJ, Schroth G. Basilar artery occlusion. Lancet Neurol. 2011;10(11):1002–1014. doi: 10.1016/S1474-4422(11)70229-0. [DOI] [PubMed] [Google Scholar]
- 2.Schonewille WJ, Algra A, Serena J, Molina CA, Kappelle LJ. Outcome in patients with basilar artery occlusion treated conventionally. J Neurol Neurosurg Psychiatry. 2005;76(9):1238–1241. doi: 10.1136/jnnp.2004.049924. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Saver JL, Goyal M, Bonafe A, et al. Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med. 2015;372(24):2285–2295. doi: 10.1056/NEJMoa1415061. [DOI] [PubMed] [Google Scholar]
- 4.Jovin TG, Chamorro A, Cobo E, et al. Thrombectomy within 8 hours after symptom onset in ischemic stroke. N Engl J Med. 2015;372(24):2296–2306. doi: 10.1056/NEJMoa1503780. [DOI] [PubMed] [Google Scholar]
- 5.Goyal M, Demchuk AM, Menon BK, et al. Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med. 2015;372(11):1019–1030. doi: 10.1056/NEJMoa1414905. [DOI] [PubMed] [Google Scholar]
- 6.Berkhemer OA, Fransen PS, Beumer D, et al. A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med. 2015;372(1):11–20. doi: 10.1056/NEJMoa1411587. [DOI] [PubMed] [Google Scholar]
- 7.van Houwelingen RC, Luijckx GJ, Mazuri A, Bokkers RP, Eshghi OS, Uyttenboogaart M. Safety and outcome of intra-arterial treatment for basilar artery occlusion. JAMA Neurol. 2016;73(10):1225–1230. doi: 10.1001/jamaneurol.2016.1408. [DOI] [PubMed] [Google Scholar]
- 8.Schönenberger S, Uhlmann L, Ungerer M, et al. Association of Blood Pressure with Short- and Long-Term Functional Outcome after Stroke Thrombectomy: post hoc analysis of the SIESTA trial. Stroke. 2018;49(6):1451–1456. doi: 10.1161/STROKEAHA.117.019709. [DOI] [PubMed] [Google Scholar]
- 9.Jadhav AP, Bouslama M, Aghaebrahim A, et al. Monitored anesthesia care vs intubation for Vertebrobasilar stroke endovascular therapy. JAMA Neurol. 2017;74(6):704–709. doi: 10.1001/jamaneurol.2017.0192. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Brinjikji W, Pasternak J, Murad MH, et al. Anesthesia-related outcomes for endovascular stroke revascularization: a systematic review and meta-analysis. Stroke. 2017;48(10):2784–2791. doi: 10.1161/STROKEAHA.117.017786. [DOI] [PubMed] [Google Scholar]
- 11.Brinjikji W, Murad MH, Rabinstein AA, Cloft HJ, Lanzino G, Kallmes DF. Conscious sedation versus general anesthesia during endovascular acute ischemic stroke treatment: a systematic review and meta-analysis. AJNR Am J Neuroradiol. 2015;36(3):525–529. doi: 10.3174/ajnr.A4159. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Just C, Rizek P, Tryphonopoulos P, Pelz D, Arango M. Outcomes of general anesthesia and conscious sedation in endovascular treatment for stroke. Can J Neurol Sci. 2016;43(5):655–658. doi: 10.1017/cjn.2016.256. [DOI] [PubMed] [Google Scholar]
- 13.Berkhemer OA, van den Berg LA, Fransen PS, et al. The effect of anesthetic management during intra-arterial therapy for acute stroke in MR CLEAN. Neurology. 2016;87(7):656–664. doi: 10.1212/WNL.0000000000002976. [DOI] [PubMed] [Google Scholar]
- 14.Simonsen CZ, Yoo AJ, Sørensen LH, et al. Effect of general anesthesia and conscious sedation during endovascular therapy on infarct growth and clinical outcomes in acute ischemic stroke: a randomized clinical trial. JAMA Neurol. 2018;75(4):470–477. doi: 10.1001/jamaneurol.2017.4474. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Löwhagen Hendén P, Rentzos A, Karlsson JE, Rosengren L, Leiram B, Sundeman H, Dunker D, Schnabel K, Wikholm G, Hellström M, Ricksten SE. General anesthesia versus conscious sedation for endovascular treatment of acute ischemic stroke: the AnStroke trial (anesthesia during stroke) Stroke. 2017;48(6):1601–1607. doi: 10.1161/STROKEAHA.117.016554. [DOI] [PubMed] [Google Scholar]
- 16.Schönenberger S, Uhlmann L, Hacke W, et al. Effect of conscious sedation vs general anesthesia on early neurological improvement among patients with ischemic stroke undergoing endovascular Thrombectomy: a randomized clinical trial. JAMA. 2016;316(19):1986–1996. doi: 10.1001/jama.2016.16623. [DOI] [PubMed] [Google Scholar]
- 17.Weber R, Minnerup J, Nordmeyer H, Eyding J, Krogias C, Hadisurya J, Berger K. REVASK investigators: Thrombectomy in posterior circulation stroke: differences in procedures and outcome compared to anterior circulation stroke in the prospective multicentre REVASK registry. Eur J Neurol. 2019;26(2):299–305. doi: 10.1111/ene.13809. [DOI] [PubMed] [Google Scholar]
- 18.Adams HP, Jr, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of org 10172 in acute stroke treatment. Stroke. 1993;24(1):35–41. doi: 10.1161/01.STR.24.1.35. [DOI] [PubMed] [Google Scholar]
- 19.Tomsick T, Broderick J, Carrozella J, et al. Revascularization results in the interventional Management of Stroke II trial. AJNR Am J Neuroradiol. 2008;29(3):582–587. doi: 10.3174/ajnr.A0843. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Gross JB, Bailey PL, Connis RT, et al. American Society of Anesthesiologists Task Force on Sedation and Analgesia by Non-Anesthesiologists: Practice guidelines for sedation and analgesia by non-anesthesiologists. Anesthesiology. 2002;96(4):1004–17. [DOI] [PubMed]
- 21.Schonewille WJ, Wijman CA, Michel P, et al. Treatment and outcomes of acute basilar artery occlusion in the basilar artery international cooperation study (BASICS): a prospective registry study. Lancet Neurol. 2009;8(8):724–730. doi: 10.1016/S1474-4422(09)70173-5. [DOI] [PubMed] [Google Scholar]
- 22.Lee PH, Burstyn I. Identification of confounder in epidemiologic data contaminated by measurement error in covariates. BMC Med Res Methodol. 2016;16:54. doi: 10.1186/s12874-016-0159-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Simonsen CZ, Sørensen LH, Juul N, Johnsen SP, Yoo AJ, Andersen G, Rasmussen M. Anesthetic strategy during endovascular therapy: general anesthesia or conscious sedation? (GOLIATH - general or local anesthesia in intra arterial therapy) a single-center randomized trial. Int J Stroke. 2016;11(9):1045–1052. doi: 10.1177/1747493016660103. [DOI] [PubMed] [Google Scholar]
- 24.Oshima T, Karasawa F, Satoh T. Effects of propofol on cerebral blood flow and the metabolic rate of oxygen in humans. Acta Anaesthesiol Scand. 2002;46(7):831–835. doi: 10.1034/j.1399-6576.2002.460713.x. [DOI] [PubMed] [Google Scholar]
- 25.Vandesteene A, Trempont V, Engelman E, Deloof T, Focroul M, Schoutens A, de Rood M. Effect of propofol on cerebral blood flow and metabolism in man. Anaesthesia. 1988;43(Suppl):42–43. doi: 10.1111/j.1365-2044.1988.tb09067.x. [DOI] [PubMed] [Google Scholar]
- 26.Abou-Chebl A, Zaidat OO, Castonguay AC, et al. North American SOLITAIRE stent-retriever acute stroke registry: choice of anesthesia and outcomes. Stroke. 2014;45(5):1396–1401. doi: 10.1161/STROKEAHA.113.003698. [DOI] [PubMed] [Google Scholar]
- 27.Whalin MK, Halenda KM, Haussen DC, et al. Even small decreases in blood pressure during conscious sedation affect clinical outcome after stroke Thrombectomy: an analysis of hemodynamic thresholds. AJNR Am J Neuroradiol. 2017;38(2):294–298. doi: 10.3174/ajnr.A4992. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Lahiri S, Schlick K, Kavi T, et al. Optimizing outcomes for mechanically ventilated patients in an era of endovascular acute ischemic stroke therapy. J Intensive Care Med. 2017;32(8):467–472. doi: 10.1177/0885066616663168. [DOI] [PubMed] [Google Scholar]
- 29.Sun J. Choice of ANesthesia for EndoVAScular treatment of acute ischemic stroke at posterior circulation: protocol for an exploratory randomized controlled study. J Neurosurg Anesthesiol. 2020;32(1):41–47. doi: 10.1097/ANA.0000000000000567. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
The datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request.